NDC 0054-0282 – Alendronate Sodium
Alendronate Sodium 70 mg/75mL · Solution · Oral
Product NDC0054-0282
Product details
- Brand name
- Alendronate Sodium
- Generic name
- Alendronate Sodium
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Dosage form
- Solution
- Route
- Oral
- Marketing category
- ANDA · ANDA090520
- Marketed since
- October 30, 2020
- Listing expires
- December 31, 2027
- Pharmacologic class
- Bisphosphonate
Active ingredients
- Alendronate Sodium 70 mg/75mL
Uses, dosage, side effects and warnings for Alendronate Sodium →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0054-0282-59 | 4 BOTTLE, UNIT-DOSE in 1 CARTON (0054-0282-59) / 75 mL in 1 BOTTLE, UNIT-DOSE | Oct 30, 2020 |
Recalls mentioning this NDC
- D-0526-2026 May 6, 2026 · Class II
This recall is being conducted due to out of specification assay results in a limited number of bottles that were stored on side.
Other Alendronate Sodium products
- 70954-264 Alendronate Sodium 70 mg/75mL · Solution · ANI Pharmaceuticals, Inc.
- 50090-3126 Alendronate Sodium 70 mg/1 · Tablet · A-S Medication Solutions
- 50090-4692 Alendronate Sodium 70 mg/1 · Tablet · A-S Medication Solutions
- 50090-5474 Alendronate Sodium 35 mg/1 · Tablet · A-S Medication Solutions
- 50090-5677 Alendronate Sodium 70 mg/1 · Tablet · A-S Medication Solutions
- 0115-1676 Alendronate Sodium 5 mg/1 · Tablet · Amneal Pharmaceuticals of New York LLC
- 0115-1678 Alendronate Sodium 10 mg/1 · Tablet · Amneal Pharmaceuticals of New York LLC
- 0115-1679 Alendronate Sodium 35 mg/1 · Tablet · Amneal Pharmaceuticals of New York LLC
- 0115-1680 Alendronate Sodium 40 mg/1 · Tablet · Amneal Pharmaceuticals of New York LLC
- 0115-1681 Alendronate Sodium 70 mg/1 · Tablet · Amneal Pharmaceuticals of New York LLC
- 65862-328 Alendronate Sodium 35 mg/1 · Tablet · Aurobindo Pharma Limited
- 65862-329 Alendronate Sodium 70 mg/1 · Tablet · Aurobindo Pharma Limited